An observational study in Corpus Uteri Carcinoma, sponsored by Centre Oscar Lambret. Completed at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-08-08.
Sponsored by Centre Oscar Lambret · Observational
Evaluate the toxicities of cervix and corpus uteri carcinomas treatment
Evaluate the toxicities of cervix and corpus uteri carcinomas treatment on sexual function after treatment (radiotherapy and/or surgery)
6,719 studies on the registry are indexed under Carcinoma; 1,142 are open to participants now.
This study's enrollment of 72 is below the median of 150 across 1,170 observational studies indexed under Carcinoma.
Browse Carcinoma studies →Centre Oscar Lambret is the lead sponsor of 130 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women with a corpus uteri carcinoma, without metastasis.
Patient with uterus adenocarcinoma, treated by surgery, then surveillance without complementary treatment
Patient with uterus adenocarcinoma, treated by surgery then adjuvant radiotherapy
patient with uterus adenocarcinoma, treated by surgery then curietherapy of vaginal dome
patient with cervix carcinoma stage IA2 to IIB, treated by surgery only
patient with cervix carcinoma stage IA2 to IIB, treated by surgery then curietherapy
patient with cervix carcinoma stage IA2 to IIB, treated by surgery then curietherapy and radiotherapy
Toxicities including on sexual function
According to Lent-Soma, NCICTC-AE v3.0, Franco-Italian Glossary
Time frame: up to 3 years
Compare the various scales of toxicity
Compare the various scales of toxicity
Time frame: up to 3 years
Study the sexual behavior modifications
According to a questionnaire and a personal discussion
Time frame: up to 3 years
Specify correlation modifications of sexual behavior
Specify the existence of a correlation between toxicities included modifications and sexual behavior modifications
Time frame: up to 3 years
Plan to share: No
No publications or documents are linked to this record.
The record gives a start of May 2009, a primary completion of May 2015 and a completion of Dec 2015. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.